Increasing number of studies demonstrated that TRPM8 channel is upregulated in various types of cancer, including prostate, pancreatic, breast, lung, and colon cancer (3–5) and is considered a valuable prognostic marker and putative therapeutic target (6). This evidence concerns the gene TRPM8 and cancer.